“Nobiletin Acts As a Potential Anticancer Agent Against Osteosarcoma by Regulating ERK and AKT Signaling Pathways”. Bangladesh Journal of Pharmacology 9, no. 3 (September 3, 2014): 406–412. Accessed June 27, 2026. https://banglajol.info/index.php/BJP/article/view/19567.